British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab.
HER2 therapy
anthracycline
echocardiography
guidelines
imaging
Journal
Echo research and practice
ISSN: 2055-0464
Titre abrégé: Echo Res Pract
Pays: England
ID NLM: 101664713
Informations de publication
Date de publication:
31 03 2021
31 03 2021
Historique:
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
10
6
2021
Statut:
epublish
Résumé
The subspecialty of cardio-oncology aims to reduce cardiovascular morbidity and mortality in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of cardiovascular complications, including left ventricular systolic dysfunction, pericardial disease, and valvular heart disease. Echocardiography is a key diagnostic imaging tool in the diagnosis and surveillance for many of these complications. The baseline assessment and subsequent surveillance of patients undergoing treatment with anthracyclines and/or human epidermal growth factor (EGF) receptor (HER) 2-positive targeted treatment (e.g. trastuzumab and pertuzumab) form a significant proportion of cardio-oncology patients undergoing echocardiography. This guideline from the British Society of Echocardiography and British Cardio-Oncology Society outlines a protocol for baseline and surveillance echocardiography of patients undergoing treatment with anthracyclines and/or trastuzumab. The methodology for acquisition of images and the advantages and disadvantages of techniques are discussed. Echocardiographic definitions for considering cancer therapeutics-related cardiac dysfunction are also presented.
Identifiants
pubmed: 34106116
doi: 10.1530/ERP-21-0001
pmc: PMC8052569
pii: ERP-21-0001
doi:
pii:
Types de publication
Journal Article
Langues
eng
Pagination
G1-G18Informations de copyright
© 2021 The authors.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this guideline.
Références
Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):977-84
pubmed: 25925220
JACC Cardiovasc Imaging. 2018 Aug;11(8):1122-1131
pubmed: 30092969
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2751-68
pubmed: 24703918
J Am Coll Cardiol. 2021 Feb 2;77(4):392-401
pubmed: 33220426
Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1063-93
pubmed: 25239940
Echo Res Pract. 2018 Jun;5(2):71-77
pubmed: 29643125
Arch Med Sci. 2014 Oct 27;10(5):1007-18
pubmed: 25395954
Cardiooncology. 2016 Apr 19;2(1):5
pubmed: 33530144
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):198-210
pubmed: 31542526
Circulation. 2015 Jun 2;131(22):1981-8
pubmed: 25948538
J Clin Oncol. 2015 Jul 1;33(19):2176-83
pubmed: 25964256
Ann Oncol. 2012 Oct;23 Suppl 7:vii155-66
pubmed: 22997448
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
Can J Cardiol. 2016 Jul;32(7):831-41
pubmed: 27343741
Europace. 2017 Sep 1;19(9):1427-1438
pubmed: 28387802
Br J Radiol. 2015 May;88(1049):20140831
pubmed: 25710361
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Clin Oncol. 2017 Mar 10;35(8):870-877
pubmed: 27893331
J Am Coll Cardiol. 2013 Jan 8;61(1):77-84
pubmed: 23199515
Echo Res Pract. 2020 Feb 24;7(1):G1-G18
pubmed: 32105051
JACC Cardiovasc Imaging. 2018 Aug;11(8):1196-1201
pubmed: 30092974
Int J Cancer. 2015 Sep 1;137(5):1176-86
pubmed: 25648592
J Am Coll Cardiol. 2010 Jan 19;55(3):213-20
pubmed: 20117401
J Am Soc Echocardiogr. 2019 Nov;32(11):1396-1406.e2
pubmed: 31679581
Cardiovasc Ultrasound. 2019 Sep 2;17(1):18
pubmed: 31477137
J Clin Oncol. 2016 Apr 1;34(10):1030-3
pubmed: 26834055
Curr Treat Options Oncol. 2019 Aug 8;20(9):73
pubmed: 31396720
JAMA Cardiol. 2020 Mar 1;5(3):309-317
pubmed: 31939997
Curr Treat Options Oncol. 2019 May 6;20(6):47
pubmed: 31056717
Future Oncol. 2015;11(1):13-5
pubmed: 25572781
Eur Heart J Cardiovasc Imaging. 2021 Mar 22;22(4):397-405
pubmed: 33555007
JACC Cardiovasc Imaging. 2018 Aug;11(8):1173-1186
pubmed: 30092972
JACC CardioOncol. 2020 Jun;2(2):345-349
pubmed: 32309816
Intern Emerg Med. 2012 Oct;7(5):439-46
pubmed: 22714882
Heart. 2003 Dec;89(12):1377-8
pubmed: 14617534
Ann Oncol. 2002 May;13(5):710-5
pubmed: 12075738
JACC Cardiovasc Imaging. 2018 Jan;11(1):15-24
pubmed: 28528147
J Clin Oncol. 2017 Mar 10;35(8):893-911
pubmed: 27918725
Circulation. 2004 Jun 8;109(22):2749-54
pubmed: 15148277
Eur Heart J. 1997 Mar;18(3):507-13
pubmed: 9076390
Echo Res Pract. 2019 Jun 13;6(3):R87-R98
pubmed: 31289687
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803
pubmed: 28461007
Eur Heart J. 2019 Jun 7;40(22):1756-1763
pubmed: 30085070
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Ann Oncol. 2020 Feb;31(2):171-190
pubmed: 31959335
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Eur J Heart Fail. 2011 Jan;13(1):1-10
pubmed: 21169385
Echo Res Pract. 2016 Sep;3(3):85-93
pubmed: 27628098
J Am Soc Echocardiogr. 2018 Feb;31(2):158-168.e1
pubmed: 29229493
Eur Heart J Cardiovasc Imaging. 2017 May 1;18(8):930-936
pubmed: 28379383
Echocardiography. 2014;31(1):87-100
pubmed: 24786629
Eur J Heart Fail. 2020 Sep;22(9):1504-1524
pubmed: 32621569
Eur Heart J Cardiovasc Imaging. 2017 Jun 1;18(6):707-716
pubmed: 27330151
Eur Heart J. 2016 Jun 1;37(21):1671-80
pubmed: 26903532
Open Heart. 2018 Jul 25;5(2):e000774
pubmed: 30094034
J Clin Oncol. 2005 Nov 1;23(31):7820-6
pubmed: 16258084
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):1-11
pubmed: 25525063
J Am Coll Cardiol. 2017 Nov 14;70(20):2536-2551
pubmed: 29145954
Echo Res Pract. 2020 Feb 27;7(1):G19-G41
pubmed: 32105053
NPJ Precis Oncol. 2017 Sep 12;1(1):31
pubmed: 29872712
Br J Hosp Med (Lond). 2017 Jan 2;78(1):C11-C13
pubmed: 28067553
Indian Heart J. 2017 Jul - Aug;69(4):556-562
pubmed: 28822531
Eur J Heart Fail. 2014 Mar;16(3):300-8
pubmed: 24464946
Card Fail Rev. 2017 Nov;3(2):97-101
pubmed: 29387460
J Am Heart Assoc. 2020 Jan 21;9(2):e014708
pubmed: 31959034
Circulation. 2007 Nov 27;116(22):2597-609
pubmed: 18040039
J Am Heart Assoc. 2020 Oct 20;9(19):e017787
pubmed: 32713239
Echo Res Pract. 2018 Sep;5(3):G11-G24
pubmed: 30012832
Echo Res Pract. 2020 Dec;7(4):G59-G93
pubmed: 33112828
Breast Cancer Res Treat. 2019 Jun;175(3):595-603
pubmed: 30852761
Clin Cardiol. 2017 Jul;40(7):437-443
pubmed: 28191909
Eur Heart J. 2019 Dec 21;40(48):3913-3920
pubmed: 31318428
Eur J Heart Fail. 2020 Nov;22(11):1945-1960
pubmed: 32463967
JACC Cardiovasc Imaging. 2018 Aug;11(8):1059-1068
pubmed: 29550306
J Am Coll Cardiol. 2018 May 22;71(20):2281-2290
pubmed: 29540327
J Thorac Dis. 2018 Dec;10(Suppl 35):S4282-S4295
pubmed: 30701097
Circ Res. 2012 Oct 26;111(10):1376-85
pubmed: 23104879
Sci Rep. 2020 Feb 27;10(1):3582
pubmed: 32107428
Clin Chem. 2005 Aug;51(8):1405-10
pubmed: 15932966
Eur Heart J Cardiovasc Imaging. 2017 Nov 1;18(11):1205-1205af
pubmed: 28950366
J Am Soc Echocardiogr. 2013 May;26(5):493-8
pubmed: 23562088